Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

RSS icon
FDA grants new Elixir Medical Dynamx implant for BTK arterial disease its breakthrough device designation

FDA grants new implant for BTK arterial disease its breakthrough device designation

Elixir Medical's DynamX BTK System is an implantable device that supports BTK vessels after PCI or other interventions.

March 21, 2024
COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology

‘Highly effective’: COVID-19 vaccines reduced risk of heart failure, other cardiovascular complications after infection

Researchers explored data from more than 20 million adults for the new study, tracking both short- and long-term outcomes. 

March 20, 2024
Kumar Madassery, MD, director of peripheral vascular intervention and critical limb ischemia (CLI) program at Rush University Medical Center in Chicago, explains techniques and tools used to restore blood flow to the foot to help foot wounds heal and prevent amputation. He is part of a campaign to raise awareness through the PAD Pulse Alliance.

Interventional techniques can help limit amputations among CLI patients

Kumar Madassery, MD, detailed some of the techniques and tools used to restore blood flow to the foot to help foot wounds heal and prevent amputation.

March 19, 2024
Biotronik has received the FDA’s breakthrough device designation for its Freesolve below-the-knee resorbable magnesium scaffold (BTK RMS) for patients with chronic limb-threatening ischemia (CLTI).

FDA grants new resorbable scaffold for CLTI its breakthrough device designation

Biotronik's Freesolve technology, which gained CE mark approval in February, is designed to maximize blood flow and minimize the post-implantation risks of stent thrombosis and target lesion revascularization.

March 18, 2024
Researchers with UVA Health in Charlottesville, Virginia, have received $2.8 million from the National Institutes of Health (NIH) to continue work on a high-tech material that could boost care for hundreds of thousands of heart patients per year.

Vascular ‘paint’ for heart patients earns researchers $2.8M in funding

“Our approach is like deploying tiny guards to protect blood vessels from going bad, so that there is no need to open the body over and over again to repair them,” one specialist explained. 

March 11, 2024
Weekly doses of semaglutide, a GLP-1 receptor originally developed to treat diabetes, could help approximately 93 million U.S. adults lose weight and reduce their risk of adverse cardiovascular events, according to new research published in Cardiovascular Drugs and Therapy. Novo Nordisk sells and markets subcutaneous treatments of semaglutide 2.4 mg under the brand name Wegovy.

A big win for Wegovy: Weight loss drug semaglutide first in history to gain FDA approval for reducing heart risks

The FDA made a special announcement about its decision, describing the news as "a major advance for public health."

March 8, 2024
Nanoflex Robotics, a healthcare technology startup based out of Switzerland, has installed its remote-ready robotics system for neurovascular procedures in the United States for the first time

Swiss startup targets stroke patients with first US install of robotics system for remote vascular interventions

The new-look robotics system can help specialists perform remote mechanical thrombectomies from bedside or as far as thousands of miles away. 

March 8, 2024
Patients who take diuretics, renin-angiotensin system (RAD) inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs) at the same time face a much higher risk of developing acute kidney injury (AKI)

Some older patients taking aspirin to prevent CVD may be doing more harm than good

“Aspirin is no longer a one-size-fits-all preventive tool for older adults," according to one specialist with Michigan Medicine. 

March 7, 2024
Displaying 17 - 24 of 1145

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup